Logistics & Transportation

Articles

Transaction expected to close early this year




Creates Cellular Origins in order to simplify the late-stage development process




North Carolina facility to manufacture Pfizer’s pipeline products 




Nottingham location expected to be fully operational by the end of 2023




Platform is expected to streamline batch turnaround times




Acquisition of Texas facility to add 60,000 square feet of manufacturing space to company’s footprint 




Provider will be CDMO’s primary material supplier in the lab, clinical, and production settings

Award given in recognition of CDMO’s commitment to promoting sustainable future 

Phoenix location will be company’s first to focus on high-density microarrays for diagnostic and life science research

CDMO will be able to produce rAAV commercial grade product